50,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This work describes the development of enantioselective oxidation reactions of carbonyl compounds using covalent organocatalysis. In the first part, asymmetric epoxidation of -branched ,beta-unsaturated aldehydes with aqueous hydrogen peroxide is presented. An exceptionally synergistic combination of a primary cinchona alkaloid-derived amine and a chiral BINOL-derived phosphoric acid was found to promote the reaction with excellent enantiocontrol for a wide variety of ,beta-disubstituted and -monosubstituted enals. Conformational analysis of catalytically relevant intermediates using NMR and…mehr

Produktbeschreibung
This work describes the development of enantioselective oxidation reactions of carbonyl compounds using covalent organocatalysis. In the first part, asymmetric epoxidation of -branched ,beta-unsaturated aldehydes with aqueous hydrogen peroxide is presented. An exceptionally synergistic combination of a primary cinchona alkaloid-derived amine and a chiral BINOL-derived phosphoric acid was found to promote the reaction with excellent enantiocontrol for a wide variety of ,beta-disubstituted and -monosubstituted enals. Conformational analysis of catalytically relevant intermediates using NMR and computational techniques enabled the rationalization of the absolute stereochemistry of products. The second part of this book describes a highly efficient direct catalytic asymmetric -benzoyloxylation of cyclic ketones. The same primary amine paired with an inorganic acid was found to be an effective catalyst for a wide range of substrates. The methodology was applied to the first asymmetricsynthesis of (+)-2beta,4-dihydroxy-1,8-cineole, a predicted terpenoid metabolite in mammals.
Autorenporträt
Olga Schöne was born Russia and educated in Russia, Canada and Germany. She obtained her PhD at the Max-Planck-Institute for Coal Research in 2012, and moved to the Ludwig Maximilians University in Munich for a postdoctoral stay in natural product synthesis. In 2014, she moved again to Austria to begin her R&D job in the pharmaceutical industry.